The Chemours Company (NYSE: CC) had its price target lowered by analysts at Truist Financial Co. from $27.00 to $22.00. They now have a "buy" rating on the stock.
LowReport
The Chemours Company (NYSE: CC) had its price target lowered by analysts at Truist Financial Co. from $27.00 to $22.00. They now have a "buy" rating on the stock.
The Chemours Company (NYSE: CC) had its price target lowered by analysts at Barclays PLC from $19.00 to $16.00. They now have an "equal weight" rating on the stock.
LowReport
The Chemours Company (NYSE: CC) had its price target lowered by analysts at Barclays PLC from $19.00 to $16.00. They now have an "equal weight" rating on the stock.
The Chemours Company (NYSE: CC) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $19.00 price target on the stock.
MediumReport
The Chemours Company (NYSE: CC) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $19.00 price target on the stock.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: